|Hardian Health||Managing Director||United Kingdom|
How far are the changing regulations impacting early-stage innovation?
Hugh is an experienced clinician and health technology advisor, with a focus on leveraging big data and artificial intelligence. He is a board certified consultant radiologist and academic, trained in the NHS and Europe’s leading cancer research center, the Institute of Cancer Research, where he was twice awarded ICR Science Writer of the Year. He is currently Managing Director at digital health consultancy Hardian Health.
He has previously held lead roles at two flagship UK startups, leading to successfully gaining the world-first CE marking for an AI-supported triage service, and the first UK CE mark for a deep-learning medical device.
He was a co-opted member of the Royal College of Radiologists informatics committee and sat on their AI policy reference group. He also acted as co-chair to the Topol health technology review for Health Education England commissioned by the Secretary of State for Health and Social Care.
He now serves as board advisor to many AI start-up companies across the globe and retains an academic interest as a board member of the global open source scientific journal Nature: Digital Medicine, and holds an honorary research fellowship at the Institute of Cognitive Neurosciences at UCL.